Document resource
All ophthalmologists will encounter patients presenting with an inherited retinal disease (IRD). Our clinical approach to IRDs has evolved over the last decade due to (1) improved and more accessible genomic sequencing technology, (2) the emergence of gene-specific therapies and (3) a wider recognition of the important roles played by clinical geneticists, genetic counsellors, molecular geneticists and genetic pathologists in a multidisciplinary IRD team. Sanders and Votruba highlight the dilemmas and hurdles ophthalmologists face when diagnosing and managing patients with IRD.1 Reasons for this include phenotypic diversity, variable access to genetic testing, difficulty in the interpretation of genetic variants and limitations of currently available genetic sequencing technology.